EVIDENCE. COMPARISONS. CLEAR NEXT STEPS.FOR US CLINIC TEAMS PROCUREMENT RESEARCH
Do-it-yourself game plans

What are the most expensive mistakes to avoid?

Dose Diligence research deskSection 02 · Page 13 of 17Last updated 17 Nov 2026
MistakeBetter approach
Comparing headline prices before checking route eligibilityEstablish product/facility/state gates first
Treating patient spending as clinic-controlled procurement spendSeparate the money flows and negotiating rights
Using introductory cash prices for a continuing forecastModel eligibility, continuing prices and expiry conditions
Using 12 four-week fills as a full year's supplyModel actual covered days and replenishment dates
Accepting a platform brand as the dispensing entityIdentify the actual pharmacy and location
Treating registration, accreditation or a licence as product-specific clearanceReview each kind of evidence for the question it actually answers
Signing minimums before a pilotTie commitments to accepted readiness and negotiated relief
Treating a legal memo as a quality audit—or vice versaObtain separate conclusions
Measuring dispatch while ignoring payment and delivery failuresTrack the full patient journey
Calling unfulfilled prescriptions “savings”Show unmet due periods alongside expenditure
Naming an untested backupVerify spare capacity and rehearse routing
Ending the project at contract signatureAssign an ongoing supplier owner

These are recommended controls, not quantified claims about the frequency of industry failures.

Explore the table row by row

A working view of the research

Comparing headline prices before checking route eligibility

Better approach
Establish product/facility/state gates first

Answers stay in this session unless you choose to save. No account needed.

Sources cited on this page

    See the section’s source register for the research context.

    Section sources →